AzTrials
AzTrials

Lumbosacral Radicular PainNCT07303309

Effectiveness of High-Voltage PRF for Chronic Lumbosacral Radicular Pain

A study testing Pulsed Radiofrequency and Post-operative Analgesia in people with Lumbosacral Radicular Pain and Chronic Radicular Back Pain, run by Hasanuddin University at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial compared high-voltage (60 V) and low-voltage (45 V) pulsed radiofrequency (PRF) for treating chronic lumbosacral radicular pain in adult patients. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Pulsed Radiofrequency and Post-operative Analgesia
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteIndonesia
Study dates
7 Feb 2025to 29 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged ≥ 18 years old
  • Numeric Rating Scale (NRS-11) ≥ 4 at screening
  • Clinical diagnosis of lumbosacral radicular pain with symptom duration ≥ 12 weeks
  • Insufficient response to conservative therapy, including but not limited to pharmacotherapy and/or physiotherapy

Who cannot join

  • Known hypersensitivity or allergy to medication required during the study (e.g., steroid, contrast media)
  • Coagulopathy, systemic infection, localized infection at needle-entry site, lumbar fracture, myelopathy, or severe organ dysfunction (e.g., renal failure, heart failure, severe respiratory diseases)
  • Comorbidities that compromise valid pain assessment (e.g., post-stroke, central neuropathy, malignancy)
  • Previous neurological deficits
  • Pregnancy
  • Refusal of participation in the study

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • RSI Sultan Agung Islamic Teaching Hospital

    Semarang, Central Java, 50112

Other trials in Indonesia

About this study

Official title: Effectiveness of High-Voltage Pulsed Radiofrequency for Chronic Lumbosacral Radicular Pain: A Randomized Controlled Trial

This randomized controlled trial compared high-voltage (60 V) and low-voltage (45 V) pulsed radiofrequency (PRF) for treating chronic lumbosacral radicular pain in adult patients. The study evaluated differences in pain reduction (using the Visual Analogue Scale [VAS] and Numeric Rating Scale [NRS-11]), functional ability (using Oswestry Disability Index scores), serum Interleukin-6 levels, and overall safety. All participants received fluoroscopy-guided PRF at 42°C for three 120-second cycles and were followed for approximately 6 weeks.

Read the detailed description

Consecutive patients who met the inclusion and exclusion criteria were enrolled and randomized into two groups: the intervention group (high-voltage PRF, 60 V) and the control group (low-voltage PRF, 45 V). The sample size was calculated using the Neyman-Pearson approach with a superiority hypothesis, assuming that the intervention group would achieve greater pain reduction than the control group. Accounting for an estimated 20% dropout rate, 11 participants were required per group. Patients who voluntarily withdrew from the study were excluded from analysis, whereas patients who discontinued the intervention due to adverse effects during or after the procedure were included in the analysis and reported.

Being tested
Pulsed Radiofrequency, Post-operative Analgesia
Keywords
pain measurement, high-voltage, pulsed radiofrequency, chronic lumbosacral radicular pain, visual analogue pain scale

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pulsed RadiofrequencyDevice

    Also called PRF

    A specialist performed fluoroscopy-guided monopolar Pulsed Radiofrequency (PRF) on a prone patient using a 22-gauge cannula (Cosman CC, CR type, 10 cm with a 10 mm active tip). Sensory stimulation prior to the procedure was applied at 200 Ohm, 50 Hz (threshold: 0.3 - 0.5 V), and motor stimulation at 2 Hz (threshold: 0.9 - 1.5 V). PRF was applied at a maximum temperature of 42 centigrade, with a frequency of 2 Hz, pulse width of 20 milliseconds, and a duration of 120 seconds per cycle for three cycles. An operating room nurse set the voltage at 45 V or 60 V.

  • Post-operative AnalgesiaDrug

    Also called Rescue Analgesia, Post-operative opioid

    Post-procedure analgesia in both groups was provided via IV fentanyl 0.5-1 µg/kg, administered as needed for patients reporting an NRS score greater than 4. This intervention was not a primary focus of the study.

Study groups in NCT07303309
Study groupRoleWhat they receive
Standard/Low-Voltage PRF at 45 VActive comparatorPulsed Radiofrequency set the voltage at 45 V.
Receives: Device: Pulsed Radiofrequency; Drug: Post-operative Analgesia
High-Voltage PRF at 60 VExperimentalPulsed Radiofrequency set the voltage at 60 V.
Receives: Device: Pulsed Radiofrequency; Drug: Post-operative Analgesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in the Numeric rating scale (NRS-11) at Follow Up

    Zero is equivalent to no pain and 10 indicates the worst possible pain.

    Measured: Baseline (pre-intervention) through study completion, an average of 6 weeks.

  2. Change from Baseline in the Visual Analog Scale (VAS) at Follow Up

    The Visual Analogue Scale (VAS) is determined by measuring the distance (in millimeters) from the patient's mark on a 100mm line to the left end of the line. The left endpoint is equivalent to "no pain" and right endpoint represents the "worst imaginable pain."

    Measured: Baseline (pre-intervention) through study completion, an average of 6 weeks.

Secondary outcomes (2)
  1. Change from Baseline in Oswestry's Disability Index Score at Follow Up

    The Oswestry Disability Index (ODI) was developed to evaluate the degree of disability associated with low back pain (LBP). An increase of 10% or more from the baseline ODI score is generally considered to indicate a clinically and statistically significant change in the patient's condition.

    Measured: Baseline (pre-intervention) through study completion, an average of 6 weeks.

  2. Change from Baseline in Serum Interleukin-6 at Follow Up

    A reduction or maintenance of serum interleukin-6 levels from baseline at follow-up.

    Measured: Baseline (pre-intervention) through study completion, an average of 6 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Dec 2025
  2. Study start7 Feb 2025
  3. Primary completion29 Apr 2025
  4. Study completion29 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Standard/Low-voltage pulsed radiofrequency (45V) was compared with high-voltage pulsed radiofrequency (60 V)
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07303309
Sponsor's protocol ID
28/KEPK-RSISA/I/2025
Status last verified
Dec 2025
First submitted
2 Dec 2025
Last updated
24 Dec 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data (IPD) underlying the results presented in future publication will be made available to facilitate additional research in this area. Excluding identifiers -such as names, addresses, and medical record numbers.

Publications

  • Deyo RA, Mirza SK. CLINICAL PRACTICE. Herniated Lumbar Intervertebral Disk. N Engl J Med. 2016 May 5;374(18):1763-72. doi: 10.1056/NEJMcp1512658. No abstract available.

    PubMed 27144851
  • Jang JN, Park S, Park JH, Song Y, Kim YU, Kim DS, Sohn JE, Park S. Output Current and Efficacy of Pulsed Radiofrequency of the Lumbar Dorsal Root Ganglion in Patients With Lumbar Radiculopathy: A Prospective, Double-blind, Randomized Pilot Study. Pain Physician. 2023 Nov;26(7):E797-E804.

    PubMed 37976483
  • Erken B, Edipoglu IS. Efficacy of High-Voltage Pulsed Radiofrequency of the Dorsal Root Ganglion for Treatment of Chronic Lumbosacral Radicular Pain: A Randomized Clinical Trial. Neuromodulation. 2024 Jan;27(1):135-140. doi: 10.1016/j.neurom.2022.10.056. Epub 2022 Dec 1.

    PubMed 36463027

Questions about this trial

What is this clinical trial studying?

A study testing Pulsed Radiofrequency and Post-operative Analgesia in people with Lumbosacral Radicular Pain and Chronic Radicular Back Pain, run by Hasanuddin University at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in the Numeric rating scale (NRS-11) at Follow Up (time frame: Baseline (pre-intervention) through study completion, an average of 6 weeks.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07303309, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in